Russian Registry of Patients With nAMD

Clinical trial NCT04935411 · TERMINATED

Trial details

NCT number: NCT04935411
Sponsor: Novartis Pharmaceuticals
Status: TERMINATED
Study type: OBSERVATIONAL

Neovascular Age-Related Macular Degeneration

Start date: 2020-12-20
Primary completion: 2022-12-05
Enrollment: 2665

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.